a month ago
RVMD
AnalystsMichael SchmidtMichael Schmidt's Stock Forecasts
AnalystsMichael Schmidt
Analyst Ranking
Top 2%
#73 out of 5200 analysts
Average Return
+50.98%
Win Rate
66%68 out of 103
Risk vs Reward
Poor
Good
Michael Schmidt's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nanobiotix SaNBTX | +658.96% | $3.27 | $24.78 | 2025-04-04 - 2026-02-20 | Strong Buy |
Urogen Pharma LtdURGN | +402.86% | $4.19 | $21.07 | 2025-05-23 - 2026-02-20 | Strong Buy |
Mersana Therapeutics IncMRSN | +291.91% | $7.42 | $29.08 | 2025-08-14 - 2026-01-05 | Strong Buy |
Cogent Biosciences IncCOGT | +281.80% | $9.78 | $37.34 | 2025-07-08 - 2026-02-20 | Strong Buy |
Compass Therapeutics IncCMPX | +265.09% | $1.69 | $6.17 | 2025-04-02 - 2026-02-20 | Strong Buy |
Michael Schmidt Analyst Color
Get additional color on Michael Schmidt's coverage of popular stocks
2 months ago
IMNM
6 months ago
CMPX
8 months ago
ADCT
a year ago
VSTM
a year ago
RVMD
a year ago
EXEL
2 years ago
EXEL
3 years ago
SNDX
3 years ago
ONC
4 years ago
ACET
Michael Schmidt's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | 2 | Strong Buy | $18.00 | +47.54% | Maintains | 17 days ago |
Nanobiotix SaNBTX | 3 | Strong Buy | $26.00 | +4.92% | Maintains | 17 days ago |
Revolution Medicines IncRVMD | 5 | Strong Buy | $160.00 | +57.12% | Maintains | a month ago |
Cytomx Therapeutics IncCTMX | 1 | Strong Buy | $10.00 | +84.16% | Initiates Coverage On | a month ago |
Monte Rosa Therapeutics IncGLUE | 2 | Strong Buy | $34.00 | +79.14% | Maintains | a month ago |
Immunome IncIMNM | 4 | Strong Buy | $35.00 | +62.79% | Maintains | 2 months ago |
Foghorn Therapeutics IncFHTX | 1 | Strong Buy | $12.00 | +109.42% | Initiates Coverage On | 4 months ago |
Incyte CorpINCY | 5 | Strong Buy | $125.00 | +23.37% | Upgrades | 4 months ago |
Genmab AGMAB | 1 | Strong Buy | $43.00 | +46.81% | Upgrades | 5 months ago |
Mersana Therapeutics IncMRSN | 4 | Strong Buy | $30.00 | +3.16% | Maintains | 6 months ago |
Adc Therapeutics SaADCT | 5 | Strong Buy | $10.00 | +143.90% | Reiterates | 6 months ago |
Oric Pharmaceuticals IncORIC | 3 | Strong Buy | $18.00 | +62.02% | Reiterates | 6 months ago |
Compass Therapeutics IncCMPX | 4 | Strong Buy | $12.00 | +94.49% | Maintains | 6 months ago |
Beone Medicines LtdONC | 7 | Strong Buy | $365.00 | +0.79% | Maintains | 7 months ago |
Arvinas IncARVN | 4 | Strong Buy | $15.00 | +25.10% | Maintains | 7 months ago |
Cogent Biosciences IncCOGT | 1 | Strong Buy | $17.00 | -54.47% | Reiterates | 7 months ago |
Arrivent Biopharma IncAVBP | 2 | Strong Buy | $45.00 | +95.74% | Reiterates | 8 months ago |
Urogen Pharma LtdURGN | 1 | Strong Buy | $15.00 | -28.81% | Maintains | 9 months ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $52.00 | -40.50% | Reiterates | 9 months ago |
Springworks Therapeutics IncSWTX | 3 | Hold | $47.00 | +0.02% | Reiterates | 9 months ago |
Relay Therapeutics IncRLAY | 1 | Strong Buy | $10.00 | +14.94% | Maintains | 10 months ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $32.00 | +62.52% | Reiterates | 10 months ago |
Merus NvMRUS | 4 | Strong Buy | $109.00 | +21.11% | Reiterates | a year ago |
Adaptimmune Therapeutics PLCADAPY | 3 | Strong Buy | $1.75 | +3,140.74% | Maintains | a year ago |
Verastem IncVSTM | 2 | Strong Buy | $14.00 | +136.09% | Maintains | a year ago |
Exelixis IncEXEL | 6 | Strong Buy | $42.00 | N/A | Reiterates | a year ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $20.00 | N/A | Reiterates | a year ago |
Zentalis Pharmaceuticals IncZNTL | 3 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Adicet Bio IncACET | 4 | Strong Buy | $112.00 | N/A | Upgrades | a year ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $92.00 | N/A | Reiterates | 2 years ago |
Immunogen IncIMGN | 1 | Hold | $31.00 | N/A | Downgrades | 2 years ago |
Xencor IncXNCR | 2 | Strong Buy | $34.00 | N/A | Maintains | 2 years ago |
Mirati Therapeutics IncMRTX | 4 | Strong Buy | $60.00 | N/A | Maintains | 3 years ago |
Blueprint Medicines CorpBPMC | 1 | Strong Buy | $82.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 3 | Strong Buy | $170.00 | N/A | Reiterates | 3 years ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Strong Buy | $22.00 | N/A | Upgrades | 3 years ago |
Neurogene IncNGNE | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Rubius Therapeutics IncRUBY | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Immuneering CorpIMRX | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 4 years ago |
Erasca IncERAS | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 5 years ago |
Rain Oncology IncRAIN2 | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 5 years ago |
Cellectis SaCLLS | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Bolt Biotherapeutics IncBOLT | 1 | Strong Buy | $840.00 | N/A | Initiates Coverage On | 5 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $39.00 | N/A | Maintains | 6 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Forty Seven IncFTSV | 1 | Strong Buy | $48.00 | N/A | Maintains | 6 years ago |
Bluebird Bio IncBLUE | 4 | Hold | N/A | N/A | Downgrades | 7 years ago |
Agios Pharmaceuticals IncAGIO | 3 | Buy | $80.00 | N/A | Upgrades | 7 years ago |
Clovis Oncology IncCLVSQ | 2 | Hold | $30.00 | N/A | Initiates Coverage On | 7 years ago |
Five Prime Therapeutics IncFPRX | 1 | Buy | $24.00 | N/A | Reinstates | 7 years ago |
Array Technologies IncARRY | 1 | Buy | $20.00 | N/A | Maintains | 8 years ago |
Juno Therapeutics IncJUNO | 2 | Hold | $87.00 | N/A | Downgrades | 8 years ago |
Arbutus Biopharma CorpABUS | 1 | Hold | $5.50 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.